BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2025 7:59:27 AM | Browse: 193 | Download: 785
 |
Received |
|
2024-07-04 22:33 |
|
Peer-Review Started |
|
2024-07-04 22:33 |
|
First Decision by Editorial Office Director |
|
2024-10-11 09:42 |
|
Return for Revision |
|
2024-10-11 09:42 |
|
Revised |
|
2024-10-24 04:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-17 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-17 08:20 |
|
Articles in Press |
|
2024-12-17 08:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-01-02 01:19 |
|
Publish the Manuscript Online |
|
2025-01-07 07:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
The first time an abbreviation appears in the manuscript, please label it with its full name. |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bahadar S Srichawla, Taranjit Kaur and Harsimran Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bahadar S Srichawla, Consultant, MS, Staff Physician, Department of Neurology, University of Massachusetts Chan Medical School, 55 Lake Ave N, Worcester, MA 01655, United States. bahadar.srichawla@umassmed.edu |
| Key Words |
Corticosteroids; Posterior reversible encephalopathy syndrome; Vasogenic edema; Reversible posterior leukoencephalopathy syndrome; Reversible cerebral vasoconstriction syndrome |
| Core Tip |
Posterior reversible encephalopathy syndrome (PRES) is characterized by headaches, seizures, confusion, and visual disturbances due to endothelial dysfunction and vasogenic edema. Corticosteroids have a dual role in PRES, potentially inducing the condition through hypertension while also treating it by reducing inflammation and stabilizing the blood-brain barrier. This systematic review identifies 57 cases of corticosteroid-induced PRES and 14 cases where corticosteroids were used therapeutically. Understanding this dual role is crucial for optimizing patient care, highlighting the need for careful monitoring and tailored treatment strategies. |
| Publish Date |
2025-01-07 07:59 |
| Citation |
Srichawla BS, Kaur T, Singh H. Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review. World J Clin Cases 2025; 13(12): 98768
|
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i12/98768.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i12.98768 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
